Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Top Glove Corporation Bhd. (7113.KL)
Shah Alam, MY
Founded in Shah Alam, Malaysia, in 1991, Top Glove Corporation Bhd. primarily operates as an investment holding company, offering comprehensive management services. The company is a major manufacturer, specializing in a wide array of gloves, including medical examination, surgical, vinyl, and nitrile varieties. Its product portfolio extends to various rubber and latex items such as concentrate and synthetic latex, formers, specialized chemicals, rubber dental dams, exercise bands, condoms, and other rubber-related goods. Top Glove also produces packaging materials, boxes, cartons, disposable and medical face masks, engineering components for rubber glove machinery, functional fillers, and a diverse range of healthcare, homecare, and personal care products. Beyond manufacturing, Top Glove provides an extensive suite of services. These include property investment, various consultancy services, and electrical engineering works. The company offers clinical and specialist medical services, alongside analytical, emergency medical, advisory, general management, and value-added support. Its operations further encompass plantation management services, the processing of plantation produce, general trading, and involvement in industrial forest plantations and associated forestry services. Additionally, Top Glove engages in trading healthcare-related products, distributing medical devices, and other hospital supplies. The company also acts as a special purpose vehicle for Perpetual Sukuk issuance, conducts in-house and public training programs, and manages fitness-oriented businesses such as healthcare centers, slimming clinics, and gymnasiums. Furthermore, it generates and supplies energy utilizing biomass technology and facilitates e-commerce for its glove and healthcare product sales. Demonstrating a strong international presence, Top Glove Corporation Bhd. distributes its products to 195 nations globally.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -13.25% | -11.11% | +29.73% | +8.27% | +11.63% | +0.70% | -21.31% | -84.58% | -7.10% | +4,792.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-06 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | 0 |
| Hold | 7 | 0 |
| Sell | 4 | +1 |
| Strong Sell | 1 | +1 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%+38.8% ★ Q2'26: +31.9% (vs Q2'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+261.7% ★ Q2'26: +134.9% (vs Q2'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+6.1% ★ Q2'26: +7.5% (vs Q2'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+4.9% Q2'26: +12.3% (vs Q2'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+2.8% Q2'26: +8.7% (vs Q2'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.1% Q2'26: +0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.78× Q2'26: 1.02× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Aug 2024 actual |
Aug 2025 actual |
Aug 2026 11 Rev. Ana. 12 EPS Ana. |
Aug 2027 17 Rev. Ana. 17 EPS Ana. |
Aug 2028 7 Rev. Ana. 8 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
2.51B
est: 2.85B (-11.8%)
|
3.49B
est: 3.64B (-4.0%)
|
4.27B
4.00B – 4.41B
+17.4% YoY
|
4.56B
3.75B – 5.86B
+6.8% YoY
|
4.91B
4.30B – 5.73B
+7.7% YoY
|
| EBITDA |
266.09M
est: 434.12M (-38.7%)
|
478.21M
est: 553.90M (-13.7%)
|
650.40M
609.31M – 671.83M
+17.4% YoY
|
694.87M
570.92M – 892.03M
+6.8% YoY
|
748.37M
655.24M – 872.86M
+7.7% YoY
|
| EBIT |
-21.40M
est: 185.97M (-111.5%)
|
172.31M
est: 237.29M (-27.4%)
|
278.63M
261.02M – 287.81M
+17.4% YoY
|
297.68M
244.58M – 382.14M
+6.8% YoY
|
320.60M
280.70M – 373.93M
+7.7% YoY
|
| Net Income |
-18.27M
est: -125.52M (+85.4%)
|
128.44M
est: 52.68M (+143.8%)
|
191.49M
156.36M – 223.38M
+263.5% YoY
|
213.29M
134.39M – 335.51M
+11.4% YoY
|
262.17M
219.75M – 318.86M
+22.9% YoY
|
| SGA |
455.88M
est: 447.83M (+1.8%)
|
481.03M
est: 571.40M (-15.8%)
|
670.95M
628.56M – 693.05M
+17.4% YoY
|
716.82M
588.96M – 920.21M
+6.8% YoY
|
772.01M
675.94M – 900.43M
+7.7% YoY
|
| EPS |
-0.01
est: -0.02 (+48.3%)
|
0.01
est: 0.01 (+99.3%)
|
0.02
0.02 – 0.03
+263.5% YoY
|
0.03
0.02 – 0.04
+11.4% YoY
|
0.03
0.03 – 0.04
+22.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-16 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-15 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-12 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-11 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-10 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-09 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-08 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-05 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-04 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-06-03 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-29 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 2/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-05 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 2/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 2/5 | 4/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.08% | 55.7K | 0.74% |
| 2 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.05% | 197.8K | 0.72% |
| 3 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.05% | 174.3K | 0.74% |
| 4 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.04% | 250.1K | 0.55% |
| 5 | Dimensional - Emerging Markets Value ETF DFEV | 0.02% | 454.9K | 0.46% |
| 6 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.02% | 67.5K | 0.33% |
| 7 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 45.7K | 0.56% |
| 8 | Vanguard Emerging Markets Ex-China ETF VEXC | 0.01% | 30.0K | 0.07% |
| 9 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.01% | 28.9K | 0.35% |
| 10 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 1.04M | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Wee Chai Lim | Founder & Executive Chairman | 3M | — |
| Hooi Sin Lim | Executive Director | 131.0K | male |
| Yong Lin Ng | Joint MD, COO & Director | 101.0K | male |
| Mun Yee Chin MAICSA | Company Secretary | — | female |
| Dorothy Ressel | Vice President of Global Marketing & Sales and Member of the Management Board | — | female |
| Thian Foong Cheng | Head of Investor Relations | — | female |
| Wei-Ann Voon | Head of Corporate Communications Department | — | female |
| Xzee Ling Loh | General Manager of Human Resources | — | female |
| Siew Chuan Chua FCIS MAICSA | Company Secretary | — | female |
| Guan Heng Ong | Senior General Manager of Compliance | — | male |
| Jin Feng Lim | Joint MD, Director of Marketing & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7113.KL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
